231 related articles for article (PubMed ID: 30924452)
21. Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
Hansel DE; Nakayama M; Luo J; Abukhdeir AM; Park BH; Bieberich CJ; Hicks JL; Eisenberger M; Nelson WG; Mostwin JL; De Marzo AM
Prostate; 2009 May; 69(6):603-9. PubMed ID: 19125417
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine differentiation of prostate cancer.
Li Z; Chen CJ; Wang JK; Hsia E; Li W; Squires J; Sun Y; Huang J
Asian J Androl; 2013 May; 15(3):328-32. PubMed ID: 23503426
[No Abstract] [Full Text] [Related]
23. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
Yuan TC; Veeramani S; Lin MF
Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine tumors of the prostate.
Fine SW
Mod Pathol; 2018 Jan; 31(S1):S122-132. PubMed ID: 29297494
[TBL] [Abstract][Full Text] [Related]
25. Development of a Transcriptional Amplification System Based on the PEG3 Promoter to Target Androgen Receptor-Positive and -Negative Prostate Cancer Cells.
Jain P; Clermont PL; Desmeules F; Zoubeidi A; Neveu B; Pouliot F
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626088
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1β promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features.
Liu Q; Russell MR; Shahriari K; Jernigan DL; Lioni MI; Garcia FU; Fatatis A
Cancer Res; 2013 Jun; 73(11):3297-305. PubMed ID: 23536554
[TBL] [Abstract][Full Text] [Related]
27. Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity.
Aggarwal RR; Quigley DA; Huang J; Zhang L; Beer TM; Rettig MB; Reiter RE; Gleave ME; Thomas GV; Foye A; Playdle D; Lloyd P; Chi KN; Evans CP; Lara PN; Feng FY; Alumkal JJ; Small EJ
Mol Cancer Res; 2019 Jun; 17(6):1235-1240. PubMed ID: 30918106
[TBL] [Abstract][Full Text] [Related]
28. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
[TBL] [Abstract][Full Text] [Related]
29. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
[TBL] [Abstract][Full Text] [Related]
30. De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome.
Abdulfatah E; Reichert ZR; Davenport MS; Chinnaiyan AM; Dadhania V; Wang X; Mannan R; Kunju LP; Hollenbeck BK; Montgomery JS; Kaffenberger SD; Morgan TM; Alva AS; Palapattu GS; Vaishampayan UN; Alumkal JJ; Spratt DE; Udager AM; Mehra R
Med Oncol; 2021 Feb; 38(3):26. PubMed ID: 33586037
[TBL] [Abstract][Full Text] [Related]
31. Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
Alshalalfa M; Liu Y; Wyatt AW; Gibb EA; Tsai HK; Erho N; Lehrer J; Takhar M; Ramnarine VR; Collins CC; Den RB; Schaeffer EM; Davicioni E; Lotan TL; Bismar TA
Int J Cancer; 2019 Dec; 145(12):3453-3461. PubMed ID: 31125117
[TBL] [Abstract][Full Text] [Related]
32. The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study.
Schron DS; Gipson T; Mendelsohn G
Cancer; 1984 Jun; 53(11):2478-80. PubMed ID: 6324985
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine differentiation in the progression of prostate cancer.
Komiya A; Suzuki H; Imamoto T; Kamiya N; Nihei N; Naya Y; Ichikawa T; Fuse H
Int J Urol; 2009 Jan; 16(1):37-44. PubMed ID: 19120524
[TBL] [Abstract][Full Text] [Related]
34. A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells.
Ding M; Lin B; Li T; Liu Y; Li Y; Zhou X; Miao M; Gu J; Pan H; Yang F; Li T; Liu XY; Li R
Oncotarget; 2015 Apr; 6(10):7686-700. PubMed ID: 25797256
[TBL] [Abstract][Full Text] [Related]
35. Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer.
Chen WY; Zeng T; Wen YC; Yeh HL; Jiang KC; Chen WH; Zhang Q; Huang J; Liu YN
Cancer Lett; 2019 Jan; 440-441():35-46. PubMed ID: 30312731
[TBL] [Abstract][Full Text] [Related]
36. Delineating the Molecular Events Underlying Development of Prostate Cancer Variants with Neuroendocrine/Small Cell Carcinoma Characteristics.
Kanayama M; Luo J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884545
[TBL] [Abstract][Full Text] [Related]
37. The role of neuroendocrine cells in prostate cancer: a comprehensive review of current literature and subsequent rationale to broaden and integrate current treatment modalities.
Lugnani F; Simone G; Biava PM; Ablin RJ
Curr Med Chem; 2014; 21(9):1082-92. PubMed ID: 24304274
[TBL] [Abstract][Full Text] [Related]
38. The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
Labrecque MP; Takhar MK; Nason R; Santacruz S; Tam KJ; Massah S; Haegert A; Bell RH; Altamirano-Dimas M; Collins CC; Lee FJ; Prefontaine GG; Cox ME; Beischlag TV
Oncotarget; 2016 Apr; 7(17):24284-302. PubMed ID: 27015368
[TBL] [Abstract][Full Text] [Related]
39. The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
Akamatsu S; Wyatt AW; Lin D; Lysakowski S; Zhang F; Kim S; Tse C; Wang K; Mo F; Haegert A; Brahmbhatt S; Bell R; Adomat H; Kawai Y; Xue H; Dong X; Fazli L; Tsai H; Lotan TL; Kossai M; Mosquera JM; Rubin MA; Beltran H; Zoubeidi A; Wang Y; Gleave ME; Collins CC
Cell Rep; 2015 Aug; 12(6):922-36. PubMed ID: 26235627
[TBL] [Abstract][Full Text] [Related]
40. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
